Glenmark Pharma’s US arm launches Clindamycin Phosphate Foam to treat acne

Share it

Glenmark Pharma Share Price | This new product is bioequivalent and therapeutically equivalent to the reference-listed drug, Evoclin Foam, 1%, manufactured by Mylan Pharmaceuticals Inc, Glenmark Pharma said in a stock exchange filing.

Leave a Comment

Your email address will not be published. Required fields are marked *